Last updated: Nov 20, 2026, 12:00 AM

Aclaris Therapeutics Inc Exchange (NASDAQ, USD)

ACRS

3.50
0.00 (0.00%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
40.56%
3 year return (CAGR)
72.65%
5 year return (CAGR)
-25.50%
10 year return (CAGR)
-16.98%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
542.45M
Price/Sales
66.00
Ent value
578.39M
Price/Book
4.35
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-15.09%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open3.53
Daily high3.62
Daily low3.44
Daily Volume1.89M
All-time high32.99
1y analyst estimate10.36
Beta0.94
EPS (TTM)-0.53
Dividend per share0.00
Ex-div date-
Next earnings date3 Mar 2026

Ready to capitalize on Aclaris Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ACRSS&P500
Current price drop from All-time high-89.39%-8.11%
Highest price drop-98.04%-56.47%
Date of highest drop13 Nov 20239 Mar 2009
Avg drop from high-64.50%-10.64%
Avg time to new high112 days12 days
Max time to new high2414 days1805 days